Morgan Stanley’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-367,295
Closed -$2.24M 8394
2021
Q3
$2.24M Sell
367,295
-118,112
-24% -$721K ﹤0.01% 4474
2021
Q2
$4M Buy
485,407
+394,224
+432% +$3.24M ﹤0.01% 4017
2021
Q1
$817K Buy
91,183
+42,862
+89% +$384K ﹤0.01% 4853
2020
Q4
$557K Sell
48,321
-484
-1% -$5.58K ﹤0.01% 5014
2020
Q3
$508K Sell
48,805
-250
-0.5% -$2.6K ﹤0.01% 4634
2020
Q2
$645K Buy
49,055
+8,319
+20% +$109K ﹤0.01% 4473
2020
Q1
$321K Sell
40,736
-42,521
-51% -$335K ﹤0.01% 4629
2019
Q4
$1.72M Sell
83,257
-983,861
-92% -$20.4M ﹤0.01% 4150
2019
Q3
$14.6M Sell
1,067,118
-1,623
-0.2% -$22.2K ﹤0.01% 1762
2019
Q2
$13.1M Sell
1,068,741
-153,407
-13% -$1.89M ﹤0.01% 1870
2019
Q1
$15.3M Sell
1,222,148
-120,082
-9% -$1.5M ﹤0.01% 1659
2018
Q4
$15.2M Buy
1,342,230
+1,248,949
+1,339% +$14.1M ﹤0.01% 1707
2018
Q3
$1.75M Sell
93,281
-12,292
-12% -$230K ﹤0.01% 4114
2018
Q2
$2.73M Buy
105,573
+11,201
+12% +$290K ﹤0.01% 3791
2018
Q1
$2.12M Sell
94,372
-19,309
-17% -$433K ﹤0.01% 3962
2017
Q4
$2.85M Buy
113,681
+41,894
+58% +$1.05M ﹤0.01% 3699
2017
Q3
$1.74M Buy
71,787
+29,028
+68% +$702K ﹤0.01% 4018
2017
Q2
$865K Sell
42,759
-904
-2% -$18.3K ﹤0.01% 4479
2017
Q1
$1.18M Sell
43,663
-53,110
-55% -$1.43M ﹤0.01% 4258
2016
Q4
$1.84M Buy
96,773
+74,046
+326% +$1.41M ﹤0.01% 4002
2016
Q3
$444K Sell
22,727
-3,230
-12% -$63.1K ﹤0.01% 4596
2016
Q2
$388K Sell
25,957
-33,166
-56% -$496K ﹤0.01% 4577
2016
Q1
$544K Buy
59,123
+40,946
+225% +$377K ﹤0.01% 4384
2015
Q4
$351K Sell
18,177
-138,359
-88% -$2.67M ﹤0.01% 4773
2015
Q3
$2.33M Buy
156,536
+143,857
+1,135% +$2.14M ﹤0.01% 3372
2015
Q2
$278K Buy
12,679
+3,128
+33% +$68.6K ﹤0.01% 5082
2015
Q1
$215K Sell
9,551
-6,818
-42% -$153K ﹤0.01% 5171
2014
Q4
$330K Buy
16,369
+4,483
+38% +$90.4K ﹤0.01% 4946
2014
Q3
$218K Buy
11,886
+10,004
+532% +$183K ﹤0.01% 5095
2014
Q2
$26K Buy
1,882
+1,305
+226% +$18K ﹤0.01% 5960
2014
Q1
$9K Buy
+577
New +$9K ﹤0.01% 6149